Phosphatidylcholine Containing Long Chain Omega-3 Fatty Acids: a Treatment Adjunct for Patients with Anorexia Nervosa?

BACKGROUND Anorexia nervosa (AN) is a serious mental disorder with a high mortality rate and often a chronic course. In contrast to many other common mental disorders, there is no drug therapy approved for AN. METHODS We performed a narrative literature review to consider whether a choline-containing molecule, such as phosphatidylcholine (PC), with an omega (ω)-3 long chain polyunsaturated fatty acid (LCPUFA) could be a potential future medicinal treatment for AN. RESULTS Choline and LCPUFAs have individually shown benefit for mental health. Case series and pilot studies suggest ω-3 LCPUFAs may be effective in eating disorders. However, pharmacodynamic and pharmacokinetic considerations suggest a greater benefit from the combination of both components. CONCLUSION The combination of a choline-containing molecule with an ω-3 LCPUFA may be clinically effective and well tolerated. This idea is supported by the current literature on the role of inflammation, the microbiome, the gut-brain-axis, hormonal, neurotransmitter and intracellular signalling, and on the structure and fluidity of nerve cells membranes in patients with AN.

[1]  N. Segata,et al.  Microbiota-gut brain axis involvement in neuropsychiatric disorders , 2019, Expert review of neurotherapeutics.

[2]  Naiman A. Khan,et al.  Dietary choline is related to neural efficiency during a selective attention task among middle-aged adults with overweight and obesity , 2019, Nutritional neuroscience.

[3]  J. Treasure,et al.  Patients’ and Carers’ Perspectives of Psychopharmacological Interventions Targeting Anorexia Nervosa Symptoms , 2019, Anorexia and Bulimia Nervosa.

[4]  B. Herpertz-Dahlmann,et al.  The Microbiome and Eating Disorders. , 2019, The Psychiatric clinics of North America.

[5]  S. Ukai,et al.  Relationship between polyunsaturated fatty acid and eating disorders: Systematic review and meta-analysis. , 2019, Prostaglandins, leukotrienes, and essential fatty acids.

[6]  J. Treasure,et al.  Genetic risk factors for eating disorders: an update and insights into pathophysiology , 2019, Therapeutic advances in psychopharmacology.

[7]  M. Abdel-Rasoul,et al.  A pilot randomized controlled trial of omega‐3 fatty acid supplementation for the treatment of anxiety in adolescents with anorexia nervosa , 2018, The International journal of eating disorders.

[8]  G. Breen,et al.  A meta-analysis of cytokine concentrations in eating disorders. , 2018, Journal of psychiatric research.

[9]  T. Dinan,et al.  Neuropsychiatric Disorders: Influence of Gut Microbe to Brain Signalling , 2018, Diseases.

[10]  J. Treasure,et al.  Psychopharmacological advances in eating disorders , 2018, Expert review of clinical pharmacology.

[11]  R. Molinari,et al.  Impact of Omega-3 Fatty Acids on the Gut Microbiota , 2017, International journal of molecular sciences.

[12]  J. German,et al.  Personalized polyunsaturated fatty acids as a potential adjunctive treatment for anorexia nervosa. , 2017, Prostaglandins & other lipid mediators.

[13]  P. Calder.  Omega-3 fatty acids and inflammatory processes: from molecules to man. , 2017, Biochemical Society transactions.

[14]  J. Blusztajn,et al.  Neuroprotective Actions of Dietary Choline , 2017, Nutrients.

[15]  J. Couturier,et al.  Acceptability and tolerability of omega-3 fatty acids as adjunctive treatment for children and adolescents with eating disorders , 2017, Eating disorders.

[16]  P. Calder.  Docosahexaenoic Acid , 2016, Annals of Nutrition and Metabolism.

[17]  F. Rybakowski,et al.  P.7.d.003 Polyunsaturated omega-3 fatty acids are not effective for depressive and compulsive symptoms in adolescent girls with anorexia nervosa , 2016, European Neuropsychopharmacology.

[18]  M. Lagarde,et al.  Efficient Docosahexaenoic Acid Uptake by the Brain from a Structured Phospholipid , 2016, Molecular Neurobiology.

[19]  S. Yehuda,et al.  The Role of Essential Fatty Acids in Anorexia Nervosa and Obesity , 2016, Critical reviews in food science and nutrition.

[20]  C. Norring,et al.  Psychiatric comorbidity in women and men with eating disorders results from a large clinical database , 2015, Psychiatry Research.

[21]  S. Mazmanian,et al.  Control of brain development, function, and behavior by the microbiome. , 2015, Cell host & microbe.

[22]  P. Calder.  Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. , 2015, Biochimica et biophysica acta.

[23]  A. Nierenberg,et al.  Inflammation as a Predictive Biomarker for Response to Omega-3 Fatty Acids in Major Depressive Disorder: A Proof of Concept Study , 2015, Molecular Psychiatry.

[24]  L. Mccargar,et al.  Estimation of choline intake from 24 h dietary intake recalls and contribution of egg and milk consumption to intake among pregnant and lactating women in Alberta , 2014, British Journal of Nutrition.

[25]  G. Grosso,et al.  Omega-3 Fatty Acids and Depression: Scientific Evidence and Biological Mechanisms , 2014, Oxidative medicine and cellular longevity.

[26]  L. Lauritzen,et al.  Fish oil-supplementation increases appetite in healthy adults. A randomized controlled cross-over trial , 2013, Appetite.

[27]  S. Akhondzadeh,et al.  Nutrients for prevention and treatment of mental health disorders. , 2013, The Psychiatric clinics of North America.

[28]  M. Berk,et al.  Dietary intake of fish and PUFA, and clinical depressive and anxiety disorders in women , 2012, British Journal of Nutrition.

[29]  P. Ritz,et al.  Anorexia nervosa patients display a deficit in membrane long chain poly-unsaturated fatty acids. , 2012, Clinical nutrition.

[30]  J. Galduróz,et al.  (N-3) Fatty acids: molecular role and clinical uses in psychiatric disorders. , 2012, Advances in nutrition.

[31]  R. Poland,et al.  Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder , 2012, Journal of clinical psychopharmacology.

[32]  B. Vessby,et al.  Omega‐3 polyunsaturated essential fatty acids are associated with depression in adolescents with eating disorders and weight loss , 2011, Acta paediatrica.

[33]  A. Mitchell,et al.  Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. , 2011, Archives of general psychiatry.

[34]  O. Manzoni,et al.  Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions , 2011, Nature Neuroscience.

[35]  S. Zeisel,et al.  Choline: an essential nutrient for public health. , 2009, Nutrition reviews.

[36]  S. Keshavarz,et al.  Comparison of Therapeutic Effects of Omega-3 Fatty Acid Eicosapentaenoic Acid and Fluoxetine, Separately and in Combination, in Major Depressive Disorder , 2008, The Australian and New Zealand journal of psychiatry.

[37]  U. Das,et al.  Essential fatty acids: biochemistry, physiology and pathology , 2006, Biotechnology journal.

[38]  D. Mostofsky,et al.  Essential fatty acids and the brain: From infancy to aging , 2005, Neurobiology of Aging.

[39]  S. Zeisel.  Nutritional Importance of Choline for Brain Development , 2004, Journal of the American College of Nutrition.

[40]  D. Horrobin,et al.  A pilot open case series of ethyl-EPA supplementation in the treatment of anorexia nervosa. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[41]  N. Aaronson,et al.  Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial , 2003, Gut.

[42]  S. Zeisel,et al.  Concentrations of choline-containing compounds and betaine in common foods. , 2003, The Journal of nutrition.

[43]  D. Horrobin,et al.  A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. , 2002, Archives of general psychiatry.

[44]  H. Steinhausen.  The outcome of anorexia nervosa in the 20th century. , 2002, The American journal of psychiatry.

[45]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[46]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.

[47]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[48]  M. Fava,et al.  Complementary and Alternative Medicine in Major Depressive Disorder , 2009 .

[49]  F. Poustka,et al.  [The importance of choline and different serum parameters for the course of the anorexia nervosa]. , 2007, Fortschritte der Neurologie-Psychiatrie.

[50]  A. Simopoulos.  Importance of the ratio of omega-6/omega-3 essential fatty acids: evolutionary aspects. , 2003, World review of nutrition and dietetics.

[51]  P. Lovibond,et al.  Manual for the Depression Anxiety Stress Scales. 2 , 1995 .